 | • レポートコード：MRC2-11QY11205 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は気管支炎治療のグローバル市場について調査・分析したレポートです。種類別（薬品、酸素療法）市場規模、用途別（病院、クリニック、ドラッグストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別気管支炎治療の競争状況、市場シェア ・世界の気管支炎治療市場：種類別市場規模 2015年-2020年（薬品、酸素療法） ・世界の気管支炎治療市場：種類別市場規模予測 2021年-2026年（薬品、酸素療法） ・世界の気管支炎治療市場：用途別市場規模 2015年-2020年（病院、クリニック、ドラッグストア） ・世界の気管支炎治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、ドラッグストア） ・北米の気管支炎治療市場分析：米国、カナダ ・ヨーロッパの気管支炎治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの気管支炎治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の気管支炎治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの気管支炎治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、GlaxoSmithKline Pharmaceuticals Limited、Sanofi Aventis、Boehringer Ingelheim、Dr. Reddy’s Laboratories Ltd ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Bronchitis is a respiratory disease in which there is inflammation of the bronchi in the lungs. In other words, bronchitis is an inflammation of the lining of bronchial tubes that carry air to and from the lungs. Some of the common signs and symptoms of bronchitis include cough, fatigue, shortness of breath, chest discomfort, production of mucus, etc.
Chronic bronchitis is a serious and long term inflammation of the bronchi of the lungs. It is one of the several lung diseases that are collectively known as chronic obstructive pulmonary diseases. Chronic bronchitis is usually caused by repeated irritation and damage of the lung and airway tissue.
Market Analysis and Insights: Global Bronchitis Treatment Market
The global Bronchitis Treatment market size is projected to reach US$ 3085.9 million by 2026, from US$ 2995.9 million in 2020, at a CAGR of 2.8%% during 2021-2026.
Global Bronchitis Treatment Scope and Market Size
Bronchitis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bronchitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
GlaxoSmithKline Pharmaceuticals Limited
Sanofi Aventis
Boehringer Ingelheim
Dr. Reddy’s Laboratories Ltd
…
Market segment by Type, the product can be split into
Drugs
Oxygen therapy
Market segment by Application, split into
Hospitals
Clinics
Drug stores
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bronchitis Treatment Revenue
1.4 Market by Type
1.4.1 Global Bronchitis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Drugs
1.4.3 Oxygen therapy
1.5 Market by Application
1.5.1 Global Bronchitis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Drug stores
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Bronchitis Treatment Market Perspective (2015-2026)
2.2 Global Bronchitis Treatment Growth Trends by Regions
2.2.1 Bronchitis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bronchitis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Bronchitis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Bronchitis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Bronchitis Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Bronchitis Treatment Players by Market Size
3.1.1 Global Top Bronchitis Treatment Players by Revenue (2015-2020)
3.1.2 Global Bronchitis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Bronchitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bronchitis Treatment Market Concentration Ratio
3.2.1 Global Bronchitis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Bronchitis Treatment Revenue in 2019
3.3 Bronchitis Treatment Key Players Head office and Area Served
3.4 Key Players Bronchitis Treatment Product Solution and Service
3.5 Date of Enter into Bronchitis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bronchitis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Bronchitis Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Bronchitis Treatment Market Size by Application (2015-2020)
5.2 Global Bronchitis Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Bronchitis Treatment Market Size (2015-2020)
6.2 Bronchitis Treatment Key Players in North America (2019-2020)
6.3 North America Bronchitis Treatment Market Size by Type (2015-2020)
6.4 North America Bronchitis Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Bronchitis Treatment Market Size (2015-2020)
7.2 Bronchitis Treatment Key Players in Europe (2019-2020)
7.3 Europe Bronchitis Treatment Market Size by Type (2015-2020)
7.4 Europe Bronchitis Treatment Market Size by Application (2015-2020)
8 China
8.1 China Bronchitis Treatment Market Size (2015-2020)
8.2 Bronchitis Treatment Key Players in China (2019-2020)
8.3 China Bronchitis Treatment Market Size by Type (2015-2020)
8.4 China Bronchitis Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Bronchitis Treatment Market Size (2015-2020)
9.2 Bronchitis Treatment Key Players in Japan (2019-2020)
9.3 Japan Bronchitis Treatment Market Size by Type (2015-2020)
9.4 Japan Bronchitis Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Bronchitis Treatment Market Size (2015-2020)
10.2 Bronchitis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bronchitis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Bronchitis Treatment Market Size by Application (2015-2020)
11 India
11.1 India Bronchitis Treatment Market Size (2015-2020)
11.2 Bronchitis Treatment Key Players in India (2019-2020)
11.3 India Bronchitis Treatment Market Size by Type (2015-2020)
11.4 India Bronchitis Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Bronchitis Treatment Market Size (2015-2020)
12.2 Bronchitis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Bronchitis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Bronchitis Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Bronchitis Treatment Introduction
13.1.4 Pfizer Revenue in Bronchitis Treatment Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 GlaxoSmithKline Pharmaceuticals Limited
13.2.1 GlaxoSmithKline Pharmaceuticals Limited Company Details
13.2.2 GlaxoSmithKline Pharmaceuticals Limited Business Overview
13.2.3 GlaxoSmithKline Pharmaceuticals Limited Bronchitis Treatment Introduction
13.2.4 GlaxoSmithKline Pharmaceuticals Limited Revenue in Bronchitis Treatment Business (2015-2020)
13.2.5 GlaxoSmithKline Pharmaceuticals Limited Recent Development
13.3 Sanofi Aventis
13.3.1 Sanofi Aventis Company Details
13.3.2 Sanofi Aventis Business Overview
13.3.3 Sanofi Aventis Bronchitis Treatment Introduction
13.3.4 Sanofi Aventis Revenue in Bronchitis Treatment Business (2015-2020)
13.3.5 Sanofi Aventis Recent Development
13.4 Boehringer Ingelheim
13.4.1 Boehringer Ingelheim Company Details
13.4.2 Boehringer Ingelheim Business Overview
13.4.3 Boehringer Ingelheim Bronchitis Treatment Introduction
13.4.4 Boehringer Ingelheim Revenue in Bronchitis Treatment Business (2015-2020)
13.4.5 Boehringer Ingelheim Recent Development
13.5 Dr. Reddy’s Laboratories Ltd
13.5.1 Dr. Reddy’s Laboratories Ltd Company Details
13.5.2 Dr. Reddy’s Laboratories Ltd Business Overview
13.5.3 Dr. Reddy’s Laboratories Ltd Bronchitis Treatment Introduction
13.5.4 Dr. Reddy’s Laboratories Ltd Revenue in Bronchitis Treatment Business (2015-2020)
13.5.5 Dr. Reddy’s Laboratories Ltd Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Bronchitis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Bronchitis Treatment Revenue
Table 3. Ranking of Global Top Bronchitis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bronchitis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drugs
Table 6. Key Players of Oxygen therapy
Table 7. Global Bronchitis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Bronchitis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Bronchitis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Bronchitis Treatment Market Share by Regions (2015-2020)
Table 11. Global Bronchitis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Bronchitis Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Bronchitis Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Bronchitis Treatment Players
Table 18. Global Bronchitis Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Bronchitis Treatment Market Share by Players (2015-2020)
Table 20. Global Top Bronchitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchitis Treatment as of 2019)
Table 21. Global Bronchitis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Bronchitis Treatment Product Solution and Service
Table 24. Date of Enter into Bronchitis Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Bronchitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Bronchitis Treatment Market Size Share by Type (2015-2020)
Table 28. Global Bronchitis Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Bronchitis Treatment Market Size Share by Application (2015-2020)
Table 30. Global Bronchitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Bronchitis Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Bronchitis Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Bronchitis Treatment Market Share (2019-2020)
Table 34. North America Bronchitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Bronchitis Treatment Market Share by Type (2015-2020)
Table 36. North America Bronchitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Bronchitis Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Bronchitis Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Bronchitis Treatment Market Share (2019-2020)
Table 40. Europe Bronchitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Bronchitis Treatment Market Share by Type (2015-2020)
Table 42. Europe Bronchitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Bronchitis Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Bronchitis Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Bronchitis Treatment Market Share (2019-2020)
Table 46. China Bronchitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Bronchitis Treatment Market Share by Type (2015-2020)
Table 48. China Bronchitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Bronchitis Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Bronchitis Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Bronchitis Treatment Market Share (2019-2020)
Table 52. Japan Bronchitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Bronchitis Treatment Market Share by Type (2015-2020)
Table 54. Japan Bronchitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Bronchitis Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Bronchitis Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Bronchitis Treatment Market Share (2019-2020)
Table 58. Southeast Asia Bronchitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Bronchitis Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Bronchitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Bronchitis Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Bronchitis Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Bronchitis Treatment Market Share (2019-2020)
Table 64. India Bronchitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Bronchitis Treatment Market Share by Type (2015-2020)
Table 66. India Bronchitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Bronchitis Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Bronchitis Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Bronchitis Treatment Market Share (2019-2020)
Table 70. Central & South America Bronchitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Bronchitis Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Bronchitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Bronchitis Treatment Market Share by Application (2015-2020)
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Product
Table 77. Pfizer Revenue in Bronchitis Treatment Business (2015-2020) (Million US$)
Table 78. Pfizer Recent Development
Table 79. GlaxoSmithKline Pharmaceuticals Limited Company Details
Table 80. GlaxoSmithKline Pharmaceuticals Limited Business Overview
Table 81. GlaxoSmithKline Pharmaceuticals Limited Product
Table 82. GlaxoSmithKline Pharmaceuticals Limited Revenue in Bronchitis Treatment Business (2015-2020) (Million US$)
Table 83. GlaxoSmithKline Pharmaceuticals Limited Recent Development
Table 84. Sanofi Aventis Company Details
Table 85. Sanofi Aventis Business Overview
Table 86. Sanofi Aventis Product
Table 87. Sanofi Aventis Revenue in Bronchitis Treatment Business (2015-2020) (Million US$)
Table 88. Sanofi Aventis Recent Development
Table 89. Boehringer Ingelheim Company Details
Table 90. Boehringer Ingelheim Business Overview
Table 91. Boehringer Ingelheim Product
Table 92. Boehringer Ingelheim Revenue in Bronchitis Treatment Business (2015-2020) (Million US$)
Table 93. Boehringer Ingelheim Recent Development
Table 94. Dr. Reddy’s Laboratories Ltd Company Details
Table 95. Dr. Reddy’s Laboratories Ltd Business Overview
Table 96. Dr. Reddy’s Laboratories Ltd Product
Table 97. Dr. Reddy’s Laboratories Ltd Revenue in Bronchitis Treatment Business (2015-2020) (Million US$)
Table 98. Dr. Reddy’s Laboratories Ltd Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bronchitis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Drugs Features
Figure 3. Oxygen therapy Features
Figure 4. Global Bronchitis Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Drug stores Case Studies
Figure 8. Bronchitis Treatment Report Years Considered
Figure 9. Global Bronchitis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Bronchitis Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Bronchitis Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Bronchitis Treatment Market Share by Players in 2019
Figure 14. Global Top Bronchitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchitis Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Bronchitis Treatment Revenue in 2019
Figure 16. North America Bronchitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Bronchitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Bronchitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Bronchitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Bronchitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Bronchitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Bronchitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
気管支炎薬の世界市場（～2026年） Market Analysis and Insights: Global Bronchitis Drug Market The global Bronchitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Bronchitis Drug Scope and Market Size Bronchitis Drug market is segmented by Type, …- 白血病治療薬の世界市場（～2026年） Leukemia Treatment Drugs is used to cure Leukemia. Increasing geriatric population base and high unmet needs regarding early diagnosis and treatment of leukemia are the key factors driving the leukemia therapeutics market. Market Analysis and Insights: Global Leukemia Treatment Drugs Market The glob…
- カルシフィラキシス治療の世界市場（～2026年） Calciphylaxis, also known as calcific uremic arteriolopathy (CUA), is a rare condition characterized by calcification or the aggregation of calcium in a patient’s blood vessels and the development of thrombosis. This can lead to the death of cells in a patient’s skin and fatty tissues, thereby causi…
- ディンプルプラスティ治療の世界市場（～2026年） Dimpleplasty, is a minimally invasive procedure used to create dimples in the face, most commonly within the cheeks. Dimple surgery is performed with incisions in the mouth behind the area in the cheek where the dimples are created. A temporary self-absorbing suture is used to create the dimple with…
- 交流電場腫瘍治療の世界市場（～2026年） Alternating electric field tumor therapy is an anticancer treatment which disrupts the tumor cells mitosis. Alternating electric field therapy is a low intensity technique which disrupts the division of cells through physical interaction of molecules during mitosis in tumor cancer. The alternating e…